Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that a detailed analysis of the Phase III ALLEGORY trial of Gazyva ® (obinutuzumab) in adults with systemic lupus ...
Ahead of International Women’s Day, new claims data from Healix Health highlights significant gender differences in health conditions and claims patterns. For ...
Millions installed 'productivity' Chrome extensions that became malware after acquisition. Here's how browser extensions became enterprise security's weakest link.
Louder for the people in the back ...
“We will never know the depths of the harm happening inside detention centers.” ...
Readers asked about what’s different for 2025, how to best manage accounts for tax purposes, and changes at the Canada Revenue Agency ...
Queerty on MSN
A surprising thing happens when conservatives are forced to watch real news, study finds
The propaganda machine can be broken, but it's not easy ...
A weakness in the configuration of OAuth credentials opens up a stored XSS vulnerability in the n8n automation platform, ...
A major new research partnership led by the University of Birmingham and the Royal Orthopaedic Hospital NHS Foundation Trust ...
Continuing where we left off last month, February saw another full schedule of podcasts here in the IFA Talk studio, including our four regular special ...
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with relapsing forms of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results